Check out your Company Bowl for anonymous work chats.
Big news! We’re excited to introduce Markus Lusser as the new President of Abcam. With 30 years of experience and a passion for the life sciences and medical device industries we’re excited about the fresh perspective and customer-centric approach that Markus brings to Abcam.
Congratulations Kirstie Speck, our VP of Digital Science, for being recognized by the “Data Science & Analytics” community at the OnCon Icon Awards. This award recognizes the top data and analytics professionals in the world and winners were voted for by their peers - go Kirstie!
Great to bring home CiteAb's ‘Antibody Supplier of the Year’ award! This ward recognizes the supplier with the most citations for antibody products in 2022. Wealso received ‘highly commended’ in the category ‘Post Translational Modification Antibody Supplier of the Year’.
Good mental health is something that we recognize as crucially important at abcam. To support our commitment to this, in 2022, we launched a new Employee Resource Group (ERG), SHIELD, focusing on the mental health of our people, globally. SHIELD is led by a group of volunteer colleagues based across our various office locations. Find out more about how your mental health is made a priority at abcam.
Have you ever wondered why the most unusual collaborations often create the most inspiring work? And how does working with new people open doors to a whole new world? That’s what Oded Rechavi, Professor at Sagol School of Neuroscience, Tel Aviv University (and Twitter legend) discusses in the second episode of #colliderscope. Listen now.
41 people, 1 breakthrough discovery. We’re celebrating the incredible researchers that discovered the BRCA2 gene with new commemorative plaques at The Institute of Cancer Research 's sites in London. The plaques highlight the phenomenal progress that can be made when scientists work together. Find out more about the plaques and where you can find them.
Not sure whether to go recombinant? Our very own Jayne Hammersley spoke with Emma Easthope about why the research community is opting more and more for recombinant antibodies. Read the article now!
We’re excited to have expanded our relationship with NanoString Technologies, Inc. to support the biomarker and clinical research communities with new tools to advance spatial multiomics research. "We are hopeful that these innovations will unlock the full potential of spatial biology and will ultimately help improve care for people with cancer" - John Baker, SVP of Marketing at Abcam. Read on to learn more.
Our very own BLOG is now live! Great insight into our culture and what we're up to. Do check it out!
Abcam is a finalist for the TIARA Talent Acquisition Awards Europe in The Kelly Services Best Innovation in Internal Recruitment Award category! We put our people at the heart of everything we do, and that includes enabling successful internal mobility to support development and retain our stellar talent! Fingers crossed for October 6th, and good luck to all the other finalists!
